Dissecting Interferon-Induced Transcriptional Programs in Human Peripheral Blood Cells
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Interferons are key modulators of the immune system, and are central to the control of many diseases. The response of immune cells to stimuli in complex populations is the product of direct and indirect effects, and of homotypic and heterotypic cell interactions. Dissecting the global transcriptional profiles of immune cell populations may provide insights into this regulatory interplay. The host transcriptional response may also be useful in discriminating between disease states, and in understanding pathophysiology. The transcriptional programs of cell populations in health therefore provide a paradigm for deconvoluting disease-associated gene expression profiles.We used human cDNA microarrays to (1) compare the gene expression programs in human peripheral blood mononuclear cells (PBMCs) elicited by 6 major mediators of the immune response: interferons alpha, beta, omega and gamma, IL12 and TNFalpha; and (2) characterize the transcriptional responses of purified immune cell populations (CD4+ and CD8+ T cells, B cells, NK cells and monocytes) to IFNgamma stimulation. We defined a highly stereotyped response to type I interferons, while responses to IFNgamma and IL12 were largely restricted to a subset of type I interferon-inducible genes. TNFalpha stimulation resulted in a distinct pattern of gene expression. Cell type-specific transcriptional programs were identified, highlighting the pronounced response of monocytes to IFNgamma, and emergent properties associated with IFN-mediated activation of mixed cell populations. This information provides a detailed view of cellular activation by immune mediators, and contributes an interpretive framework for the definition of host immune responses in a variety of disease settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288 · cited 1×
“The datasets discussed in this publication have been deposited in the Stanford Microarray Database [65], and NCBI’s Gene Expression Omnibus [66] and are accessible through GEO Series accession number GSE17762 [67].”
MethodDistinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationDAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“. Genes encoding proteins implicated in the major antiviral pathways initiated by interferon stimulation were consistently induced, including the dsRNA-dependent protein kinase pathway (PRKRA, EIF2AK2 (PRKR), PALM2-AKA1, EIF2B1), the 2-5A synthetase system (OAS1/2/3), and the Mx pathway (MX1/2). Genes involved in the…”
BackgroundHOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · cited 4×
“Numerous transcripts encoding proteins whose roles remain to be fully characterized were also significantly induced G1P2, G1P3 (6–16), IFI27, IFI35, IFI44, IFIT1/5, IFITM1 (9–27), IFITM2/3, IFRD1, IFRG28, ISG20, as previously described [14].”
BackgroundInfluentialInterferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160 · cited 1×
“Type I IFN stimulation induces a number of different systems involved in the activation of the immune response, cell growth and the control of apoptosis, in addition to the PKR (dsRNA-dependent protein kinase), 2-5A synthetase and Mx antiviral systems [7,8].”
BackgroundSTEM: a tool for the analysis of short time series gene expression data
Ernst, J., & Bar-Joseph, Z. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-191 · Cited by 1,703 · cited 5×
“The significantly differentially expressed genes (determined using the SAM algorithm, minimum 2 fold cutoff at a false discovery rate of ,1% of the median), and sampled at 0.5, 1, 4, 8, 12 and 24 h post IFNc treatment, were separated into 7 significantly represented profiles using STEM.”
MethodInfluentialInterferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617 · cited 1×
“Interferons are involved in a wide range of clinically important phenomena, ranging from activation of immune responses to infection [14] to cancer suppression [16] to depression [17].”
BackgroundCytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235 · cited 1×
“Interferons are involved in a wide range of clinically important phenomena, ranging from activation of immune responses to infection [14] to cancer suppression [16] to depression [17].”
BackgroundRadomska, H. S., Huettner, C. S., Zhang, P., Cheng, T., Scadden, D. T., & Tenen, D. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4301 · Cited by 466 · cited 1×
“example, the transcription factors C/EBPa, involved in myeloid cell differentiation [62] and associated with acute myeloid leukemias [63], and MHC2TA (CIITA), the major regulator controlling expression of MHC class II molecules [50], were both preferentially induced by type II IFN (in PBMCs compared to type I IFNs and…”
BackgroundFunction and regulation of MHC class II molecules in T-lymphocytes: of mice and men
Holling, T. M., Schooten, E., & van Den Elsen, P. J. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.01.005 · Cited by 334
Cell-type specific gene expression profiles of leukocytes in human peripheral blood
Palmer, C., Diehn, M., Alizadeh, A. A., & Brown, P. O. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-115 · Cited by 331 · cited 1×
“87610–74 respectively) [39].”
Self-citationDimitriou, I. D., Clemenza, L., Scotter, A. J., Chen, G., Guerra, F. M., & Rottapel, R. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00659.x · Cited by 184
Chae, H.-D., Lee, K. E., Williams, D. A., & Gu, Y. (2008) · Blood · doi:10.1182/blood-2007-06-093237 · Cited by 81 · cited 1×
“RHOH, a repressor of Rac GTPase-mediated signaling (specifically RAC1) [46], was also induced immediately after IFNc treatment; conversely, RAC1 was repressed with time (Figure 4a, profile G).”
BackgroundZimmerer, J. M., Lesinski, G. B., Ruppert, A. S., Radmacher, M. D., Noble, C., Kendra, K., Walker, M. J., & Carson, W. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0846 · Cited by 33 · cited 1×
“IFN signatures have been identified as prominent aspects of many transcriptional profiles [25–28].”
BackgroundRhoH/TTF Negatively Regulates Leukotriene Production in Neutrophils
Daryadel, A., Yousefi, S., Troi, D., Schmid, I., Schmidt-Mende, J., Mordasini, C., Dahinden, C. A., Ziemiecki, A., & Simon, H.-U. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803846 · Cited by 20
Cited by
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
“The major mediators of IFN-g-induced signaling, STAT1, JAK2, and IRF1, and regulators cytokine inducible SH2-containing protein (CISH), N-myc-interactor (NMI), protein tyrosine phosphatase, receptor type, C PTPRC, protein tyrosine phosphatase, receptor type, O (PTPRO), and suppressor of cytokine signaling 1 (SOCS1) ar…”
BackgroundInterferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
“IFN-γ controls specific gene expression programs involving more than 290 genes related to cytokine and chemokine receptors, cell activation markers, cellular adhesion proteins, MHC proteins, proteasome formation, protein turnover, and signaling mediators and regulators (134).”
BackgroundType I Interferon in the Pathogenesis of Lupus
Crow, M. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1002795 · Cited by 561
Cooke, K. R., Luznik, L., Sarantopoulos, S., Hakim, F. T., Jagasia, M., Fowler, D. H., van den Brink, M. R. M., Hansen, J. A., Parkman, R., Miklos, D. B., et al. (2017) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2016.09.023 · Cited by 472
Type I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses
Teles, R. M. B., Graeber, T. G., Krutzik, S. R., Montoya, D., Schenk, M., Lee, D. J., Komisopoulou, E., Kelly-Scumpia, K., Chun, R., Iyer, S. S., et al. (2013) · Science · doi:10.1126/science.1233665 · Cited by 380
Self-citation
Metadata
- Authors
- Waddell, S. J., Popper, S. J., Rubins, K. H., Griffiths, M. J., Brown, P. O., Levin, M., & Relman, D. A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-03-22
- Volume
- 5
- Issue
- 3
- Pages
- e9753
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2045210787
- Cited by
- 144
- References
- 18
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.